Head and Neck Cancer Diagnostics Market Size (2024 - 2029)

The head and neck cancer diagnostics market is projected to experience significant growth over the forecast period, driven by an increasing prevalence of head and neck cancers and a rising geriatric population. The market's expansion is further supported by the growing adoption of advanced diagnostic techniques such as endoscopy, MRI, and CT scans, which are essential for accurate diagnosis and treatment planning. Despite the challenges posed by the COVID-19 pandemic, the market is recovering as healthcare services resume and awareness initiatives by research institutes enhance understanding of the disease. However, the high cost of diagnostic devices and reimbursement issues may pose challenges to market growth.

Market Size of Head and Neck Cancer Diagnostics Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Head and Neck Cancer Diagnostics Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 5.73 Billion
Market Size (2029) USD 9.92 Billion
CAGR (2024 - 2029) 11.62 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Head and Neck Cancer Diagnostics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Head and Neck Cancer Diagnostics Market Analysis

The Head and Neck Cancer Diagnostics Market size is estimated at USD 5.73 billion in 2024, and is expected to reach USD 9.92 billion by 2029, growing at a CAGR of 11.62% during the forecast period (2024-2029).

The COVID-19 pandemic has affected healthcare systems globally and significantly impacted the head and neck cancer diagnosis market. For instance, as per the article published in the Sage Journal in December 2021, approximately 88% of cancer centers across 54 countries reported difficulties in providing care, suggesting the pandemic's significant impact on cancer care. Early in the pandemic, there were proponents of delaying care for patients with mild symptoms of head and neck cancers (HNCs), given the vulnerability of this patient population to pulmonary complications associated with the virus. Thus, the COVID-19 pandemic has impacted the head and neck cancer diagnostics market. However, since the lockdown restrictions were lifted, the industry has been recovering well. Post-pandemic, the market is expected to gain traction over the coming years because of declining COVID-19 cases and the resumption of hospital services.

The growing burden of head and neck cancer and the rising geriatric population are expected to propel the market's growth over the forecast period. Oropharyngeal cancer is the most common type of head and neck cancer. It can affect several areas in and around the mouth, including the lips and tongue. According to the 2022 American Cancer Society Report, there were around 11 230 fatal cases and 54,000 new cases of the oral cavity or oropharyngeal cancer, respectively, in the United States. Thus, the increasing prevalence of head and neck cancer is expected to raise demand for its early diagnosis, thereby boosting the market's growth over the forecast period.

Additionally, a growing number of diagnostic procedures for head and neck cancer is expected to propel the growth of the market. Endoscopy, head MRI, CT of the sinuses, head CT, panoramic dental x-ray, dental cone beam CT, PET/CT, or chest imaging is utilized to confirm a cancer diagnosis and determine the spread of malignancy. The increased adoption of these diagnostic techniques is expected to boost market growth over the forecast period. For instance, according to the study published in the American Journal of Roentgenology in November 2022, CT, MRI, and FDG PET/CT all play essential roles in the diagnosis, staging, therapy planning, and monitoring of head and neck cancers. Thus, the availability of several diagnostic techniques for head and neck cancer is expected to propel the growth of the market.

Moreover, various strategies taken by research institutes to increase awareness about head and neck cancer are expected to support market growth. For instance, in May 2021, the Head and Neck Cancer Alliance (HNCA) and PDS Biotechnology Corporation established a collaboration. This cooperation aims to improve knowledge of novel and developing treatment options for individuals with HPV-related head and neck cancer diagnoses, including available clinical trials.

Thus, all the factors above, such as the growing burden of head and neck cancer, are expected to boost the market over the forecast period. However, the high cost of diagnostic devices and reimbursement issues may restrain the market's growth.

Head and Neck Cancer Diagnostics Industry Segmentation

As per the scope of the report, head and neck cancers usually originate in the squamous cells that line the mouth, nose, and throat. The typical symptoms include a persistent sore throat, difficulty swallowing, mouth sores that won't heal, a hoarse voice, and persistent neck swelling from enlarged lymph nodes. The market is segmented by Diagnostic Method (Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Bioscopy Screening Tests, Dental Diagnostic Methods, Other Diagnostic Methods), End-User (Hospitals, Diagnostic Centers, Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Diagnostic Method
Diagnostic Imaging Equipment
Endoscopy Screening Equipment
Bioscopy Screening Tests
Dental Diagnostic Methods
Other Diagnostic Methods
By End User
Hospitals
Diagnostic Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Head and Neck Cancer Diagnostics Market Size Summary

The head and neck cancer diagnostics market is poised for significant growth over the forecast period, driven by the increasing prevalence of head and neck cancers and the rising geriatric population. The market is recovering from the disruptions caused by the COVID-19 pandemic, which had previously impacted cancer care delivery. As healthcare services resume normal operations, the demand for early diagnosis of head and neck cancers is expected to rise, fueled by the growing burden of these cancers. The market is characterized by the adoption of advanced diagnostic techniques such as endoscopy, MRI, CT scans, and PET/CT imaging, which are crucial for accurate diagnosis and staging of cancers. These technological advancements are anticipated to propel market growth, alongside efforts by research institutions to raise awareness and improve treatment options for head and neck cancer patients.

North America is projected to hold a significant share of the head and neck cancer diagnostics market, supported by the high adoption of cancer diagnostic technologies and a substantial cancer burden in the region. Initiatives like Oral, Head, and Neck Cancer Awareness Week and product launches by key market players are expected to further drive market expansion. The market is consolidated, with major players such as GE Healthcare, Philips, and Siemens Healthineers leading the way in research and distribution. Despite challenges like high diagnostic device costs and reimbursement issues, the market is set to grow, bolstered by new product approvals and the increasing use of diagnostic imaging technologies.

Explore More

Head and Neck Cancer Diagnostics Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising in Incidences of Target Diseases

      2. 1.2.2 Growing Global Geriatric Population

      3. 1.2.3 Technological Advancments and Increasing Number of Diagnostic Procedures for Head and Neck Cancer

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of the Devices and Unfavourable Reimbursement Scenarios

      2. 1.3.2 Dearth of Trained Professionals

    4. 1.4 Porter Five Forces

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Diagnostic Method

      1. 2.1.1 Diagnostic Imaging Equipment

      2. 2.1.2 Endoscopy Screening Equipment

      3. 2.1.3 Bioscopy Screening Tests

      4. 2.1.4 Dental Diagnostic Methods

      5. 2.1.5 Other Diagnostic Methods

    2. 2.2 By End User

      1. 2.2.1 Hospitals

      2. 2.2.2 Diagnostic Centers

      3. 2.2.3 Other End Users

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Head and Neck Cancer Diagnostics Market Size FAQs

The Head and Neck Cancer Diagnostics Market size is expected to reach USD 5.73 billion in 2024 and grow at a CAGR of 11.62% to reach USD 9.92 billion by 2029.

In 2024, the Head and Neck Cancer Diagnostics Market size is expected to reach USD 5.73 billion.

Head and Neck Cancer Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)